ERBB2 and metastatic malignant neoplasm in the lymph nodes: In a smaller study, authors noted higher HER2 expression in patients with liver metastases compared to those with peritoneal metastases, which led to the speculation that HER2 overexpression may promote liver metastases but not necessarily peritoneal and lymph node metastases.24